|
"liu tw"的相關文件
顯示項目 61-85 / 139 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2016-10-01 |
The influence of hospital volume on disease outcomes of advanced uterine cervical cancer patients: A nationwide cohort study of Taiwan
|
Hong, JH;Lin, SM;Ku, HY;Liu, TW;Chang, TC |
| 國家衛生研究院 |
2016-10 |
The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study
|
Kao, HF;Hsiao, CF;Lai, SC;Wang, CW;Ko, JY;Lo, PJ;Lee, TJ;Liu, TW;Hong, RL |
| 國家衛生研究院 |
2016-09 |
Trend in and correlates of undergoing radiotherapy in Taiwanese cancer patients' last month of life
|
Hung, YN;Cheng, SH;Liu, TW;Chang, WC;Chen, JS;Tang, ST |
| 國家衛生研究院 |
2016-08 |
Characteristics and correlates of increasing use of surgery in Taiwanese cancer patients' last month of life, 2001-2010
|
Liu, TW;Hung, YN;Earle, CC;Liu, TP;Liu, LN;Tang, ST |
| 國家衛生研究院 |
2016-07 |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
|
Hsu, CH;Tseng, CH;Chiang, CJ;Hsu, KH;Tseng, JS;Chen, KC;Wang, CL;Chen, CY;Yen, S;Chiu, CH;Huang, MS;Yu, CJ;Tsai, YH;Chen, JS;Tsai, CM;Chou, TY;Lin, KC;Tsai, MH;Lee, WC;Ku, HY;Liu, TW;Yang, TY;Chang, GC |
| 國家衛生研究院 |
2016-04 |
Receipt of life-sustaining treatments for Taiwanese pediatric patients who died of cancer in 2001 to 2010: A retrospective cohort study
|
Hung, YN;Liu, TW;Lin, DT;Chen, YC;Chen, JS;Tang, ST |
| 國家衛生研究院 |
2016-01 |
S-1 with leucovorin for gastric cancer: How far can it go?
|
Liu, TW;Chen, LT |
| 國家衛生研究院 |
2016-01 |
A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial
|
Chen, MH;Lin, J;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-12 |
Breast cancer quality of care in Taiwan in relation to hospital volume: A population-based cohort study
|
Ou-Yang, F;Hsu, NC;Juan, CH;Huang, HI;Moi, SH;Chen, FM;Liu, TW;Hou, MF |
| 國家衛生研究院 |
2015-12 |
A decade of changes in preferences for life-sustaining treatments among terminally Ill patients with cancer
|
Tang, ST;Liu, TW;Wen, FH;Hsu, C;Chang, YH;Chang, CS;Sung, YC;Hsieh, CI;Chang, SY;Liu, LN;Chiang, MC |
| 國家衛生研究院 |
2015-12 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial
|
Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-11 |
Determinants of hospital death for Taiwanese pediatric cancer decedents, 2001–2010
|
Hung, YN;Liu, TW;Tang, ST |
| 國家衛生研究院 |
2015-08 |
Increasing receipt of high-tech/high-cost imaging and its determinants in the last month of Taiwanese patients with metastatic cancer, 2001-2010: A retrospective cohort study
|
Liu, TW;Hung, YN;Soong, TC;Tang, ST |
| 國家衛生研究院 |
2015-05 |
Preferences for aggressive end-of-life care and their determinants among Taiwanese terminally Ill cancer patients
|
Liu, LN;Chen, CH;Liu, TW;Lin, YC;Lee, SC;Tang, ST |
| 國家衛生研究院 |
2015-05 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial
|
Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-04 |
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide
|
Liang, PC;Ch'ang, HJ;Hsu, C;Chen, LT;Shih, TTF;Liu, TW |
| 國家衛生研究院 |
2015-04 |
Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Chuang, MH;Chen, CL;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C |
| 國立交通大學 |
2014-12-08T15:39:38Z |
Emission characteristics and control efficiency of acidic and basic gases and aerosols from packed towers
|
Tsai, CJ; Chang, CT; Liu, TW; Huang, CC; Chien, CL; Chein, HM |
| 國家衛生研究院 |
2014-12 |
Physician-patient end-of-life care discussions: Correlates and associations with end-of-life care preferences of cancer patients-a cross-sectional survey study
|
Tang, ST;Liu, TW;Liu, LN;Chiu, CF;Hsieh, RK;Tsai, CM |
| 國家衛生研究院 |
2014-07 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 國家衛生研究院 |
2014-06 |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu, C;Tsou, HH;Lin, SJ;Wang, MC;Yao, M;Hwang, WL;Kao, WY;Chiu, CF;Lin, SF;Lin, J;Chang, CS;Tien, HF;Liu, TW;Chen, PJ;Cheng, AL |
| 國家衛生研究院 |
2014-05 |
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: A phase II TCOG study
|
Wang, LW;Hsiao, CF;Chen, WTL;Lee, HH;Lin, TC;Chen, HC;Chen, HH;Chien, CR;Lin, TY;Liu, TW |
| 臺北醫學大學 |
2014 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates amongTaiwanese terminally ill cancer patients surveyed in2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 國家衛生研究院 |
2012-10 |
Development and validation of an instrument for the measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective
|
Chang, HH;Chie, WC;Chin, YH;Hsu, CP;Liu, TW;Whang-Peng, J |
| 國家衛生研究院 |
2012-04 |
Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001-2006
|
Liu, TW;Chang, WC;Wang, HM;Chen, JS;Koong, SL;Hsiao, SC;Tang, ST |
顯示項目 61-85 / 139 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
|
